SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Bates Grant R (Last) (First) (Middle) 2 HOUSTON CENTER 909 FANNIN ST., SUITE 3100 (Street) HOUSTON TX 77010 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 10/01/2015	3. Issuer Name and Ticker or Trading Symbol MRC GLOBAL INC. [ MRC ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) SVP-Cdn Ops, Glob QHSE & Op Ex	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	17,544(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to Buy)	(2)	05/08/2022	Common Stock	47,505	21.05	D
Stock Options (Right to Buy)	(3)	03/07/2023	Common Stock	4,925	29.35	D
Stock Options (Right to Buy)	(4)	02/18/2024	Common Stock	4,046	29.3	D

Explanation of Responses:

1. On 3/7/2013, the reporting person received 675 restricted shares (the "March 2013 Grant") of common stock, par value $0.01 per share, of MRC Global Inc. (the "Common Stock"). 20% of the March 2013 Grant vested on each of 3/7/2014 and 3/7/2015. Of the remaining March 2013 Grant, 20% will vest on each of 3/7/2016, 3/7/2017 and 3/7/2018, each conditioned on the reporting person's continued service with the issuer and subject to accelerated vesting under certain circumstances. On 2/18/2014, the reporting person received 1,650 restricted shares (the "February 2014 Grant") of Common Stock. 25% of the February 2014 Grant vested on 2/18/2015. Of the remaining February 2014 Grant, 25% will vest on each of 2/18/2016, 2/18/2017 and 2/18/2018, each conditioned on the reporting person's continued service with the issuer and subject to accelerated vesting under certain circumstances. On 2/17/2015, the reporting person received 15,219 Restricted Stock Units (the "February 2015 Grant"). Each Restricted Stock Unit represents a contingent right to receive one share of issuer's Common Stock. 34% of the February 2015 Grant will vest on 2/17/2016, and 33% of the February 2015 Grant will vest on each of 2/17/2017 and 2/17/2018, each conditioned on the reporting person's continued service with the issuer and subject to accelerated vesting under certain circumstances.

2. 20% of the options reported above vested and became exercisable on each of 5/8/2013, 5/8/2014 and 5/8/2015 and 20% of the options reported above will vest and become exercisable on each of 5/8/2016 and 5/8/2017, each conditioned on the reporting person's continued service with the issuer and subject to accelerated vesting under certain circumstances.

3. 25% of the options reported above vested and became exercisable on each of 3/7/2014 and 3/7/2015, and 25% of the options reported above will vest and become exercisable on each of 3/7/2016 and 3/7/2017, each conditioned on the reporting person's continued service with the issuer and subject to accelerated vesting under certain circumstances.

4. 33% of the options reported above vested and became exercisable on 2/18/2015. 33% of the options reported above will vest and become exercisable 2/18/2016, and 34% of the options reported above will vest and become exercisable on 2/18/2017, each conditioned on the reporting person's continued service with the issuer and subject to accelerated vesting under certain circumstances.

	Ann D. Garnett	10/13/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

LIMITED POWER OF ATTORNEY

The undersigned, being an executive officer of MRC Global Inc.
(the ?Corporation?), who will hereby be subject to the reporting
obligations of Section 16 of the Securities Exchange Act of 1934,
as amended (the ?Act?), with respect to securities of the Corporation,
hereby constitutes and appoints, with full power of substitution or
revocation, each of Daniel J. Churay and Ann D. Garnett, or such
attorney-in-fact?s substitute or substitutes, as the undersigned?s
true and lawful attorneys-in-fact and agents to execute and file for
and on behalf of the undersigned Forms 3, 4 and 5 with the Securities
and Exchange Commission (the ?SEC?), and to perform all acts necessary
in order to execute and file such Forms 3, 4 and 5, as he or she, as
applicable, shall deem appropriate.  The undersigned hereby ratifies
and confirms all that said attorneys-in-fact and agents, or such
attorney-in-fact?s substitute or substitutes, shall do or cause to
be done by virtue hereof.

The undersigned acknowledges that the foregoing attorneys-in-fact,
in serving in such capacity at the request of the undersigned, or
such attorney-in-fact?s substitute or substitutes, are not assuming,
nor is the Corporation assuming, any of the undersigned?s
responsibilities to comply with Section 16 of the Act.  This Limited
Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned?s holdings of and transactions in securities
issued by the Corporation, unless earlier revoked by the undersigned in
a signed writing delivered to the foregoing attorneys-in-fact.

This Limited Power of Attorney is effective as of October 1, 2015,
and any previous power of attorney issued by the undersigned for the
purpose of executing and filing Forms 3, 4 and 5 with the SEC with
respect to holdings of and transactions in securities issued by the
Corporation is hereby revoked (without affecting the effectiveness of
any such power of attorney prior to the date hereof).



					Grant R. Bates